Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s stock price was up 6.8% during mid-day trading on Thursday. The stock traded as high as GBX 0.15 and last traded at GBX 0.11. Approximately 139,376,188 shares traded hands during mid-day trading, an increase of 400% from the average daily volume of 27,868,387 shares. The stock had previously closed at GBX 0.10.
Oxford BioDynamics Trading Up 6.8%
The stock has a market cap of £14.79 million, a PE ratio of -0.55 and a beta of 0.42. The company has a debt-to-equity ratio of 131.61, a quick ratio of 2.80 and a current ratio of 2.01. The stock has a fifty day moving average price of GBX 0.11 and a 200 day moving average price of GBX 0.18.
About Oxford BioDynamics
Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Recommended Stories
- Five stocks we like better than Oxford BioDynamics
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
